Mitsubishi Tanabe Pharma
Japanese pharmaceuticals company, a subsidiary of mitsubishi chemical holdings corporation.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | $3.3b Valuation: $3.3b | Buyout | |
| Total Funding | 000k | ||
| JPY | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 10 % | 5 % | (5 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 13 % | 14 % | 13 % | 13 % |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 5 % | 6 % | 4 % | 4 % |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Mitsubishi Tanabe Pharma
Edit
ACQUISITION by Mitsubishi Tanabe Pharma Jul 2017
ACQUISITION Jan 2013
ACQUISITION by Mitsubishi Tanabe Pharma Jul 2013
